Drug and Therapeutics Bulletin 2001;39:85-87; doi:10.1136/dtb.2001.391185
Copyright © 2001 by the BMJ Publishing Group Ltd.
Levonorgestrel intra-uterine system for menorrhagia
Relevant BNF section: 7.3.2.3
In 1996, we concluded that the levonorgestrel intra-uterine system (levonorgestrel IUS; Mirena - Schering Health Care) was an effective contraceptive.1 The product is now also licensed as a treatment for "idiopathic menorrhagia", with the claim that it "may be particularly useful in women with idiopathic menorrhagia requiring (reversible) contraception".2 We assess the efficacy and safety of levonorgestrel IUS in the management of heavy menstrual bleeding.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Phillips, V, Graham, C T, Manek, S, McCluggage, W G
(2003). The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J. Clin. Pathol.
56: 305-307
[Abstract] [Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
